| Year |
Citation |
Score |
| 2013 |
Conway KL, Kuballa P, Khor B, Zhang M, Shi HN, Virgin HW, Xavier RJ. ATG5 regulates plasma cell differentiation. Autophagy. 9: 528-37. PMID 23327930 DOI: 10.4161/Auto.23484 |
0.303 |
|
| 2011 |
Mahowald GK, Mahowald MA, Moon C, Khor B, Sleckman BP. Out-of-frame T cell receptor beta transcripts are eliminated by multiple pathways in vivo. Plos One. 6: e21627. PMID 21765899 DOI: 10.1371/Journal.Pone.0021627 |
0.782 |
|
| 2009 |
Callén E, Bunting S, Huang CY, Difilippantonio MJ, Wong N, Khor B, Mahowald G, Kruhlak MJ, Ried T, Sleckman BP, Nussenzweig A. Chimeric IgH-TCRalpha/delta translocations in T lymphocytes mediated by RAG. Cell Cycle (Georgetown, Tex.). 8: 2408-12. PMID 19556863 DOI: 10.4161/Cc.8.15.9085 |
0.753 |
|
| 2009 |
Khor B, Mahowald GK, Khor K, Sleckman BP. Functional overlap in the cis-acting regulation of the V(D)J recombination at the TCRbeta locus. Molecular Immunology. 46: 321-6. PMID 19070901 DOI: 10.1016/J.Molimm.2008.10.030 |
0.768 |
|
| 2006 |
Khor B, Bredemeyer AL, Huang CY, Turnbull IR, Evans R, Maggi LB, White JM, Walker LM, Carnes K, Hess RA, Sleckman BP. Proteasome activator PA200 is required for normal spermatogenesis Molecular and Cellular Biology. 26: 2999-3007. PMID 16581775 DOI: 10.1128/Mcb.26.8.2999-3007.2006 |
0.717 |
|
| 2005 |
Khor B, Sleckman BP. Intra- and inter-allelic ordering of T cell receptor beta chain gene assembly. European Journal of Immunology. 35: 964-70. PMID 15719363 DOI: 10.1002/Eji.200425806 |
0.705 |
|
| 2005 |
Khor B, Wehrly TD, Sleckman BP. Chromosomal excision of TCRdelta chain genes is dispensable for alphabeta T cell lineage commitment. International Immunology. 17: 225-32. PMID 15642954 DOI: 10.1093/Intimm/Dxh202 |
0.74 |
|
| 2005 |
Jackson A, Kondilis HD, Khor B, Sleckman BP, Krangel MS. Regulation of T cell receptor beta allelic exclusion at a level beyond accessibility. Nature Immunology. 6: 189-97. PMID 15640803 DOI: 10.1038/Ni1157 |
0.65 |
|
| 2004 |
Tillman RE, Wooley AL, Hughes MM, Khor B, Sleckman BP. Regulation of T-cell receptor beta-chain gene assembly by recombination signals: the beyond 12/23 restriction. Immunological Reviews. 200: 36-43. PMID 15242394 DOI: 10.1111/J.0105-2896.2004.00156.X |
0.759 |
|
| 2003 |
Brewer JA, Khor B, Vogt SK, Muglia LM, Fujiwara H, Haegele KE, Sleckman BP, Muglia LJ. T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation. Nature Medicine. 9: 1318-22. PMID 12949501 DOI: 10.1038/Nm895 |
0.621 |
|
| 2003 |
Tillman RE, Wooley AL, Khor B, Wehrly TD, Little CA, Sleckman BP. Cutting edge: targeting of V beta to D beta rearrangement by RSSs can be mediated by the V(D)J recombinase in the absence of additional lymphoid-specific factors. Journal of Immunology (Baltimore, Md. : 1950). 170: 5-9. PMID 12496374 DOI: 10.4049/Jimmunol.170.1.5 |
0.741 |
|
| 2002 |
Khor B, Sleckman BP. Allelic exclusion at the TCRbeta locus. Current Opinion in Immunology. 14: 230-4. PMID 11869897 DOI: 10.1016/S0952-7915(02)00326-6 |
0.679 |
|
| 1999 |
Monroe RJ, Sleckman BP, Monroe BC, Khor B, Claypool S, Ferrini R, Davidson L, Alt FW. Developmental regulation of TCR delta locus accessibility and expression by the TCR delta enhancer. Immunity. 10: 503-13. PMID 10367896 DOI: 10.1016/S1074-7613(00)80050-3 |
0.65 |
|
| 1998 |
Sleckman BP, Bassing CH, Bardon CG, Okada A, Khor B, Bories JC, Monroe R, Alt FW. Accessibility control of variable region gene assembly during T-cell development. Immunological Reviews. 165: 121-30. PMID 9850857 DOI: 10.1111/J.1600-065X.1998.Tb01235.X |
0.732 |
|
| 1998 |
Sleckman BP, Khor B, Monroe R, Alt FW. Assembly of productive T cell receptor delta variable region genes exhibits allelic inclusion. The Journal of Experimental Medicine. 188: 1465-71. PMID 9782123 DOI: 10.1084/Jem.188.8.1465 |
0.737 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2020 |
Varma M, Kadoki M, Lefkovith A, Conway KL, Gao K, Mohanan V, Tusi BK, Graham DB, Latorre IJ, Tolonen AC, Khor B, Ng A, Xavier RJ. Cell Type- and Stimulation-Dependent Transcriptional Programs Regulated by Atg16L1 and Its Crohn's Disease Risk Variant T300A. Journal of Immunology (Baltimore, Md. : 1950). PMID 32522834 DOI: 10.4049/Jimmunol.1900750 |
0.273 |
|
| 2021 |
Arnett A, Moo KG, Flynn KJ, Sundberg TB, Johannessen L, Shamji AF, Gray NS, Decker T, Zheng Y, Gersuk VH, Rahman ZS, Levy DE, Marié IJ, Linsley PS, Xavier RJ, ... Khor B, et al. The CDK8 inhibitor DCA promotes a tolerogenic chemical immunophenotype in CD4 T cells via a novel CDK8-GATA3-FOXP3 pathway. Molecular and Cellular Biology. MCB0008521. PMID 34124936 DOI: 10.1128/MCB.00085-21 |
0.248 |
|
| 2016 |
Khor B. Regulatory T Cells: Central Concepts from Ontogeny to Therapy. Transfusion Medicine Reviews. PMID 27523957 DOI: 10.1016/j.tmrv.2016.07.003 |
0.239 |
|
| 2015 |
Khor B, Gagnon JD, Goel G, Roche MI, Conway KL, Tran K, Aldrich LN, Sundberg TB, Paterson AM, Mordecai S, Dombkowski D, Schirmer M, Tan PH, Bhan AK, Roychoudhuri R, et al. The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells. Elife. 4. PMID 25998054 DOI: 10.7554/Elife.05920 |
0.226 |
|
| 2022 |
Kim S, Ko E, Choi HG, Kim D, Luchi M, Khor B, Kim S. FRTX-02, a selective and potent inhibitor of DYRK1A, modulates inflammatory pathways in mouse models of psoriasis and atopic dermatitis. Journal of Translational Autoimmunity. 6: 100185. PMID 36654851 DOI: 10.1016/j.jtauto.2022.100185 |
0.199 |
|
| 2008 |
Khor B, Makar RS. Toward a molecular explanation for cross-presentation of antigens to the immune system. Transfusion Medicine Reviews. 22: 188-201. PMID 18572095 DOI: 10.1016/j.tmrv.2008.02.002 |
0.194 |
|
| 2021 |
Marie IJ, Brambilla L, Azzouz D, Chen Z, Baracho GV, Arnett A, Li HS, Liu W, Cimmino L, Chattopadhyay P, Silverman G, Watowich SS, Khor B, Levy D. Tonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiome. Elife. 10. PMID 34378531 DOI: 10.7554/eLife.68371 |
0.193 |
|
| 2019 |
Khor B, Conway KL, Omar AS, Biton M, Haber AL, Rogel N, Baxt LA, Begun J, Kuballa P, Gagnon JD, Lassen KG, Regev A, Xavier RJ. Distinct Tissue-Specific Roles for the Disease-Associated Autophagy Genes ATG16L2 and ATG16L1. Journal of Immunology (Baltimore, Md. : 1950). PMID 31451676 DOI: 10.4049/Jimmunol.1800419 |
0.164 |
|
| 2013 |
Shaw SY, Tran K, Castoreno AB, Peloquin JM, Lassen KG, Khor B, Aldrich LN, Tan PH, Graham DB, Kuballa P, Goel G, Daly MJ, Shamji AF, Schreiber SL, Xavier RJ. Selective modulation of autophagy, innate immunity, and adaptive immunity by small molecules. Acs Chemical Biology. 8: 2724-33. PMID 24168452 DOI: 10.1021/Cb400352D |
0.156 |
|
| 2017 |
Johannessen L, Sundberg TB, O'Connell DJ, Kolde R, Berstler J, Billings KJ, Khor B, Seashore-Ludlow B, Fassl A, Russell CN, Latorre IJ, Jiang B, Graham DB, Perez JR, Sicinski P, et al. Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells. Nature Chemical Biology. PMID 28805801 DOI: 10.1038/Nchembio.2458 |
0.114 |
|
| 2016 |
Sundberg TB, Liang Y, Wu H, Choi HG, Kim ND, Sim T, Johannessen L, Petrone A, Khor B, Graham DB, Latorre IJ, Phillips AJ, Schreiber SL, Perez J, Shamji AF, et al. Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function In Vivo. Acs Chemical Biology. PMID 27224444 DOI: 10.1021/Acschembio.6B00217 |
0.112 |
|
| 2014 |
Kadauke S, Khor B, Van Cott EM. Activated protein C resistance testing for factor V Leiden. American Journal of Hematology. 89: 1147-50. PMID 25293789 DOI: 10.1002/Ajh.23867 |
0.106 |
|
| 2012 |
Johnson NV, Khor B, Van Cott EM. Advances in laboratory testing for thrombophilia. American Journal of Hematology. 87: S108-12. PMID 22473489 DOI: 10.1002/ajh.23186 |
0.1 |
|
| 2023 |
Khor B, Buckner JH. Down syndrome: insights into autoimmune mechanisms. Nature Reviews. Rheumatology. 1-2. PMID 37147460 DOI: 10.1038/s41584-023-00970-0 |
0.099 |
|
| 2011 |
Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 474: 307-17. PMID 21677747 DOI: 10.1038/nature10209 |
0.09 |
|
| 2014 |
Sundberg TB, Choi HG, Song JH, Russell CN, Hussain MM, Graham DB, Khor B, Gagnon J, O'Connell DJ, Narayan K, Dan?ík V, Perez JR, Reinecker HC, Gray NS, Schreiber SL, et al. Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cells. Proceedings of the National Academy of Sciences of the United States of America. 111: 12468-73. PMID 25114223 DOI: 10.1073/Pnas.1412308111 |
0.088 |
|
| 2016 |
Van Cott EM, Khor B, Zehnder JL. Factor V Leiden. American Journal of Hematology. 91: 46-9. PMID 26492443 DOI: 10.1002/ajh.24222 |
0.087 |
|
| 2009 |
Khor B, Van Cott EM. Laboratory evaluation of hypercoagulability. Clinics in Laboratory Medicine. 29: 339-66. PMID 19665682 DOI: 10.1016/j.cll.2009.03.002 |
0.087 |
|
| 2010 |
Khor B, Van Cott EM. Laboratory tests for protein C deficiency. American Journal of Hematology. 85: 440-2. PMID 20309856 DOI: 10.1002/ajh.21679 |
0.083 |
|
| 2010 |
Khor B, Van Cott EM. Laboratory tests for antithrombin deficiency. American Journal of Hematology. 85: 947-50. PMID 21108326 DOI: 10.1002/ajh.21893 |
0.083 |
|
| 2022 |
Lambert K, Moo KG, Arnett A, Goel G, Hu A, Flynn KJ, Speake C, Wiedeman AE, Gersuk VH, Linsley PS, Greenbaum CJ, Long SA, Partridge R, Buckner JH, Khor B. Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunity. Science Translational Medicine. 14: eabi4888. PMID 35020411 DOI: 10.1126/scitranslmed.abi4888 |
0.08 |
|
| 2021 |
Asif M, Khor B. Two roads diverged: Emerging lessons from IVIG about hemolysis. Transfusion. 61: 993-995. PMID 33831225 DOI: 10.1111/trf.16326 |
0.05 |
|
| 2021 |
Hendrix JA, Amon A, Abbeduto L, Agiovlasitis S, Alsaied T, Anderson HA, Bain LJ, Baumer N, Bhattacharyya A, Bogunovic D, Botteron KN, Capone G, Chandan P, Chase I, Chicoine B, ... ... Khor B, et al. Opportunities, barriers, and recommendations in down syndrome research. Translational Science of Rare Diseases. 5: 99-129. PMID 34268067 DOI: 10.3233/trd-200090 |
0.023 |
|
| Hide low-probability matches. |